ENTRY       D11042            Mixture   Drug
NAME        Tezacaftor and ivacaftor;
            Symdeko (TN)
PRODUCT     SYMDEKO (Vertex Pharmaceuticals Incorporated)
COMPONENT   Tezacaftor [DR:D11041], Ivacaftor [DR:D09916]
REMARK      ATC code: R07AX31
            Product: D11042<US>
EFFICACY    Cystic fibrosis treatment
  DISEASE   Cystic fibrosis (CFTR F508del homozygous mutation) [DS:H00218]
            Cystic fibrosis (at least one mutation in CFTR) [DS:H00218]
TARGET      CFTR* [HSA_VAR:1080v1] [HSA:1080] [KO:K05031]
  PATHWAY   hsa02010(1080)  ABC transporters
            hsa04971(1080)  Gastric acid secretion
            hsa04972(1080)  Pancreatic secretion
            hsa04976(1080)  Bile secretion
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             R RESPIRATORY SYSTEM
              R07 OTHER RESPIRATORY SYSTEM PRODUCTS
               R07A OTHER RESPIRATORY SYSTEM PRODUCTS
                R07AX Other respiratory system products
                 R07AX31 Ivacaftor and tezacaftor
                  D11042  Tezacaftor and ivacaftor &lt;US&gt;
            USP drug classification [BR:br08302]
             Respiratory Tract/Pulmonary Agents
              Cystic Fibrosis Agents
               Conductance Regulator Potentiator
                Tezacaftor/ Ivacaftor
                 D11042  Tezacaftor and ivacaftor
            Target-based classification of drugs [BR:br08310]
             Transporters
              ABC transporters
               ABCC subfamily
                CFTR* [HSA_VAR:1080v1]
                 D11042  Tezacaftor and ivacaftor &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11042
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11042
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11042
            Pharmacogenomic biomarkers [br08341.html]
             Germline mutations in genetic disorder treatments
              D11042
DBLINKS     CAS: 1969264-35-4
            PubChem: 355052576
///
